Sale of 1,215 shares at $850.0 per share.
Reporting Person McCourt Marion · Officer Title EVP Commercial · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001663758-26-000002 · filed 2026-09-03 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "REGENERON PHARMACEUTICALS, INC. (REGN)." Disclosed 2026-09-03. https://desqlong.com/cards/0001663758-26-000002-1 (retrieved 2026-09-26).
